Prostate cancer.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Disease-a-month : DM

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/b978-1-4160-6643-9.00095-3PMID 2019219
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The predictive accuracy of staging transurethral resection of the prostate in the management of stage A cancer of the prostate: a comparative evaluation.

  1990cited by this paper
• Nerve-sparing radical prostatectomy: evaluation of results after 250 patients.

  1990cited by this paper
• Intraoperative and early complications of staging pelvic lymph node dissection in prostatic adenocarcinoma.

  1990cited by this paper
• Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen.

  1990cited by this paper
• Stage B prostate adenocarcinoma. Flow cytometric nuclear DNA ploidy analysis.

  1990cited by this paper
• Cancer statistics, 1990

  1990cited by this paper
• Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial.

  1990cited by this paper
• Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose.

  1990cited by this paper
• Complete androgen blockade: data from an EORTC 30853 trial.

  1990cited by this paper
• Bowel complications after radiotherapy for carcinoma of the prostate: the volume effect.

  1990cited by this paper
• Radical nerve-sparing prostatectomy with epidural anaesthesia in 100 patients.

  1990cited by this paper
• Epidemiologic evidence regarding predisposing factors to prostate cancer

  1990cited by this paper
• Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia.

  1990cited by this paper
• Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients.

  1989cited by this paper
• Relative value of prostate-specific antigen and prostatic acid phosphatase in diagnosis and management of adenocarcinoma of prostate. Ohio State University experience.

  1989cited by this paper
• Prostate‐specific antigen and premalignant change: Implications for early detection

  1989cited by this paper
• Progression and complications after external beam radiation therapy for carcinoma of prostate.

  1989cited by this paper
• The role of transrectal ultrasound in the early detection of prostate cancer

  1989cited by this paper
• A controlled trial of leuprolide with and without flutamide in prostatic carcinoma.

  1989cited by this paper
• Prognostic significance of DNA ploidy in carcinoma of prostate.

  1989cited by this paper
• Cohort study of diet, lifestyle, and prostate cancer in adventist men

  1989cited by this paper
• Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients.

  1989cited by this paper
• Stage C prostatic adenocarcinoma: flow cytometric nuclear DNA ploidy analysis.

  1989cited by this paper
• Extended follow-up of stage A1 carcinoma of prostate.

  1989cited by this paper
• Use of transrectal ultrasound in detection of prostatic carcinoma: A preliminary report

  1989cited by this paper
• Cause-specific actuarial survival analysis: a useful method for reporting survival data in men with clinically localized carcinoma of the prostate.

  1989cited by this paper
• Beta‐carotene and animal fats and their relationship to prostate cancer risk. A case—control study

  1989cited by this paper
• Treatment of locally advanced prostate cancer with radiation therapy.

  1989cited by this paper
• Status of radiation treatment of prostate cancer at Stanford University.

  1989cited by this paper
• A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii.

  1989cited by this paper
• Cancer patient survival rates: Seer program results for 10 years of follow‐up

  1989cited by this paper
• Natural history of localised prostatic cancer. A population-based study in 223 untreated patients.

  1989cited by this paper
• Total prostatectomy for clinically localized prostatic cancer: long-term results.

  1989cited by this paper
• The value of serum prostate specific antigen determinations before and after radical prostatectomy.

  1989cited by this paper
• Extended experience with surgical treatment of stage D1 adenocarcinoma of prostate. Significant influences of immediate adjuvant hormonal treatment (orchiectomy) on outcome.

  1989cited by this paper
• Phase III studies to compare goserelin (Zoladex) with orchiectomy and with diethylstilbestrol in treatment of prostatic carcinoma.

  1989cited by this paper
• High-dose ketoconazole in advanced hormone-refractory prostate cancer: endocrinologic and clinical effects.

  1989cited by this paper
• Histologic grade, clinical stage, and patient age in prostate cancer.

  1988cited by this paper
• Significance of duct‐acinar dysplasia in prostatic carcinogenesis

  1988cited by this paper
• The prognostic value of DNA ploidy combined with histologic substaging for incidental carcinoma of the prostate gland.

  1988cited by this paper
• Prediagnostic serum hormones and the risk of prostate cancer.

  1988cited by this paper
• Iodine-125 implants versus external beam therapy for stages A2, B, and C prostate cancer.

  1988cited by this paper
• Local control of prostate cancer with radiotherapy: frequency and prognostic significance of positive results of postirradiation prostate biopsy.

  1988cited by this paper
• A Case‐Control Study of Prostatic Cancer With Reference to Dietary Habits

  1988cited by this paper
• Prostate Cancer: Comparison of Transrectal US and Digital Rectal Examination for Screening

  1988cited by this paper
• More on the Uro-Oncology Research Group report of radical surgery vs. radiotherapy for adenocarcinoma of the prostate.

  1988cited by this paper
• Selection criteria for radical prostatectomy based on morphometric studies in prostate carcinoma.

  1988cited by this paper
• Racial differences in cancer incidence: The significance of age‐specific patterns

  1988cited by this paper
• Radiation therapy for localized prostate carcinoma: experience at the Massachusetts General Hospital (1973-1981).

  1988cited by this paper
• Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan

  1988cited by this paper
• Radical prostatectomy after radiation therapy for cancer of the prostate: feasibility and prognosis.

  1988cited by this paper
• Relationship of DNA content to conventional prognostic factors in clinically localised carcinoma of the prostate.

  1988cited by this paper
• Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.

  1988cited by this paper
• Prostatic carcinoma: staging with MR imaging at 1.5 T.

  1988cited by this paper
• Definitive radiation therapy in carcinoma of the prostate localized to the pelvis: experience at the Mallinckrodt Institute of Radiology.

  1988cited by this paper
• Treatment options for patients with stage D1 (T0-3,N1-2,M0) adenocarcinoma of prostate.

  1988cited by this paper
• DNA distribution patterns of prostatic tissue obtained at time of transurethral resection.

  1988cited by this paper
• Flow cytometric determination of ploidy in prostatic adenocarcinoma: a comparison with seminal vesicle involvement and histopathological grading as a predictor of clinical recurrence.

  1988cited by this paper
• Androgen priming and chemotherapy in advanced prostate cancer: evaluation of determinants of clinical outcome.

  1988cited by this paper
• The role of radiation therapy in stages A2 and B adenocarcinoma of the prostate.

  1988cited by this paper
• Combined interstitial and external irradiation for prostatic cancer.

  1987cited by this paper
• Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate.

  1987cited by this paper
• The use of ketoconazole as an inhibitor of steroid production.

  1987cited by this paper
• Prostate cancer: new hope for early diagnosis.

  1987cited by this paper
• DNA flow cytometry and histopathological grading of paraffin-embedded prostate biopsy specimens in a survival study.

  1987cited by this paper
• A ten year follow-up of 682 patients treated for prostate cancer with radiation therapy in the United States.

  1987cited by this paper
• Interstitial irradiation using I-125 seeds.

  1987cited by this paper
• Correlation of radiotherapeutic parameters and treatment related morbidity in carcinoma of the prostate--analysis of RTOG study 75-06.

  1987cited by this paper
• Anandron (RU 23908) associated to surgical castration in previously untreated stage D prostate cancer: a multicenter comparative study of two doses of the drug and of a placebo.

  1987cited by this paper
• The role of radical prostatectomy in the management of prostatic cancer

  1987cited by this paper
• Tumour markers in prostatic carcinoma. A comparison of prostate-specific antigen with acid phosphatase.

  1987cited by this paper
• Prostate cancer. Chemotherapy

  1987cited by this paper
• Early experience with Walsh technique of radical retropubic prostatectomy.

  1987cited by this paper
• Medical, life‐style, and occupational risk factors for prostate cancer

  1987cited by this paper
• Carcinoma of the prostate. Hormonal therapy

  1987cited by this paper
• Computerized tomography and transrectal ultrasound in the assessment of local extension of prostatic cancer before radical retropubic prostatectomy.

  1987cited by this paper
• Prostatic carcinoma: staging by clinical assessment, CT, and MR imaging.

  1987cited by this paper
• The abnormal prostate: MR imaging at 1.5 T with histopathologic correlation.

  1987cited by this paper
• Metastatic cancer of the prostate managed with buserelin versus buserelin plus cyproterone acetate.

  1987cited by this paper
• Radiation therapy as adjuvant treatment after radical prostatectomy: patient tolerance and preliminary results.

  1986cited by this paper
• Evaluation of prostate-specific antigen and prostatic acid phosphatase as prostate cancer markers.

  1986cited by this paper
• Long-term followup of young patients with stage A adenocarcinoma of the prostate.

  1986cited by this paper
• The prevalence of cancer. Estimates based on the Connecticut Tumor Registry.

  1986cited by this paper
• The value of computerized tomography scan and magnetic resonance imaging in staging prostatic carcinoma: comparison with the clinical and histological staging.

  1986cited by this paper
• Patterns of progression in prostate cancer.

  1986cited by this paper
• Adjuvant radiotherapy following radical prostatectomy: results and complications.

  1986cited by this paper
• Transrectal ultrasound in the diagnosis of prostate cancer: Location, echogenicity, histopathology, and staging

  1986cited by this paper
• Prostatic carcinoma cell DNA content measured by flow cytometry and its relation to clinical outcome

  1986cited by this paper
• Preoperative evaluation of localized prostatic carcinoma by transrectal ultrasonography.

  1985cited by this paper
• Incidental carcinoma of the prostate: significance of staging transurethral resection.

  1985cited by this paper
• Familial factors affecting prostatic cancer risk and plasma sex‐steroid levels

  1985cited by this paper
• Salvage surgery following radical radiotherapy for adenocarcinoma of the prostate.

  1985cited by this paper
• Blood transfusion and anesthetic practices in radical retropubic prostatectomy.

  1985cited by this paper
• Complete androgen blockade for the treatment of prostate cancer.

  1985cited by this paper
• Lymphangiography in genitourinary cancer.

  1985cited by this paper
• Computed tomography of the lower urinary tract.

  1985cited by this paper
• Relationship between DNA ploidy, glandular differentiation, and tumor spread in human prostate cancer.

  1985cited by this paper
• Androgen receptor assays in advanced prostatic cancer.

  1984cited by this paper
• Total prostatectomy for localized prostatic cancer.

  1984cited by this paper
• Ketoconazole therapy in advanced prostatic cancer.

  1984cited by this paper

• Mitigating bias in prostate cancer diagnosis using synthetic data for improved AI driven Gleason grading

  2025cites this paper
• Prostate-specific antigen/prostatic acid phosphatase ratio is significant prognostic factor in patients with stage IV prostate cancer.

  2007cites this paper
• Prognostic factors in prostate cancer

  2006cites this paper
• Liarozole--a novel treatment approach for advanced prostate cancer: results of a large randomized trial versus cyproterone acetate. Liarozole Study Group.

  1998cites this paper
• Comparative analysis of prognostic factors in men undergoing radical prostatectomy for adenocarcinoma of the prostate, including DNA ploidy, surgical tumor stage, prostatic specific antigen, Gleason grade, and age

  1996cites this paper
• Theoretical and experimental analysis of air cooling for intracavitary microwave hyperthermia applicators

  1994cites this paper
• Why so many operations for localised prostate cancer?

  1994cites this paper
• Malignant pleural effusion from prostatic adenocarcinoma resolved with hormonal therapy.

  1994cites this paper